1. Sanofi to acquire UK’s Vicebio for $1.6b, to pocket vaccine candidates
  2. AstraZeneca to invest $50 billion in US, to build new drug facility
  3. AstraZeneca’s therapy for a type of lung cancer helps patients live longer 
  4. AI platforms for psychiatric patients show racial bias: Cedars-Sinai
  5. AstraZeneca’s trial drug for AL amyloidosis fails to meet survival goal
  6. US regulator clears Biocon’s diabetic biosimilar product for Novolog
  7. ViiV to grant generic access to its HIV medicine to benefit 133 nations
  8. Neuroaesthetics: Art is not a luxury of soul, it is a language of the brain
  9. Zimmer Biomet to buy Monogram Technologies for $177 million
  10. Funding shortage, conflicts hinder infant vaccination progress: UNICEF
  11. Northern Arizona resident dies of pneumonic plague, first since 2007
  12. AbbVie inks $2 billion deal with IGI, bags antibody to fight cancer 
  13. Gilead, Global Fund to supply HIV prevention drug to two million people
  14. FDA calls on infant foodmakers to be transparent on product recalls
  15. FDA permits slow dosing of Eli Lilly’s Alzheimer’s drug Kisunla
Vicebio will receive potential milestone payments of up to $450 million based on development and regulatory achievements.

Sanofi to acquire UK’s Vicebio for $1.6b, to pocket vaccine candidates

  • July 22, 2025
Swedish-British AstraZeneca Plc. plans to build a new facility in the US to manufacture drug components for weight management and metabolism, and invest $50 billion in the country over five years.

AstraZeneca to invest $50 billion in US, to build new drug facility

  • July 22, 2025
AstraZeneca Plc’s therapy for a certain type of advanced lung cancer, in combination with chemotherapy, helped patients live longer, company data from an end-stage study reveals.

AstraZeneca’s therapy for a type of lung cancer helps patients live longer 

  • July 21, 2025
Artificial intelligence platforms for psychiatric patients are showing a pattern of racial bias by proposing different treatments for people of colour, a small Cedars-Sinai study finds.

AI platforms for psychiatric patients show racial bias: Cedars-Sinai

  • July 17, 2025
AstraZeneca Plc’s investigational drug to treat AL amyloidosis, a rare and serious disease affecting the heart and kidneys, failed to meet its main goal of helping people to live longer.
Drugs Health Pharma

AstraZeneca’s trial drug for AL amyloidosis fails to meet survival goal

The US Food and Drug Administration has approved a biosimilar product made by India’s Biocon Biologics Ltd., a subsidiary of Biocon Ltd., to treat diabetes mellitus in adults and pediatric patients.
Drugs Health Pharma

US regulator clears Biocon’s diabetic biosimilar product for Novolog

ViiV Healthcare, majority owned by GSK, has signed a pact with the UN-backed Medicines Patent Pool (MPP) to enable generic access to its HIV treatment in 133 countries.
Drugs Health Pharma

ViiV to grant generic access to its HIV medicine to benefit 133 nations

As the neural code of beauty unfolds, one truth becomes clear: art is not a mere luxury of the soul. It is a language the brain inherently understands.
Drugs Health Opinion

Neuroaesthetics: Art is not a luxury of soul, it is a language of the brain

Zimmer Biomet Holdings, Inc. will acquire Monogram Technologies Inc., an orthopaedic robotics company, for $177 million to expand its robotics portfolio.
Drugs Health Medical

Zimmer Biomet to buy Monogram Technologies for $177 million

Research

Research
Artificial intelligence platforms for psychiatric patients are showing a pattern of racial bias by proposing different treatments for people of colour, a small Cedars-Sinai study finds.
Health Medical Research

AI platforms for psychiatric patients show racial bias:

A new and faster method of detecting and measuring radioactivity of tiny amounts of radioactive material has been developed by researchers at the National Institute of Standards and Technology (NIST), America’s national measurement institute.
Health, Medical, Research

NIST invents new technology to measure tiny

  • July 9, 2025
A new artificial intelligence model developed by researchers at Johns Hopkins University can predict whether a patient is likely to experience a cardiac arrest much better than doctors, who rely on limited clinical symptoms.
Health, Medical, Research

Doctors step aside, AI can predict patients

  • July 7, 2025
Scientists can tell how fast or gracefully you are ageing from a single magnetic resonance image of your brain, according to researchers at Duke University.
Health, Medical, Research

Duke researchers’ tool helps know how fast

  • July 7, 2025
A sponge-like material with long, microscopic air pockets that uses sunlight and a simple plastic cover can turn saltwater into freshwater, according to Chinese researchers.
Climate, Health, Research

Chinese researchers use aerogels, sunlight to desalinate

  • July 6, 2025
A majority of clinical research on adult Attention Deficit Hyperactivity Disorder (ADHD) suffers from serious methodological shortcomings, making it difficult to use the results in practice, according to researchers from the University of Copenhagen and the University of São Paulo.
Drugs, Health, Research

Researchers find serious flaws in clinical trials

  • July 2, 2025
Medical experts at Cincinnati Children’s have made an organoid, or ‘organs in a dish,’ of human lung tissue that produces its own blood vessels, according to a statement.
Drugs, Health, Research

Cincinnati team’s lab-made lung tissue produces its

  • July 1, 2025

Opinion

As the neural code of beauty unfolds, one truth becomes clear: art is not a mere luxury of the soul. It is a language the brain inherently understands.
Drugs, Health, Opinion

Neuroaesthetics: Art is not a luxury of soul, it is a language of the brain

Dog with a family
Health, Opinion

Balancing work and companionship; choosing the right dog for your lifestyle

Men haunted by a Yakshi are not victims of a supernatural encounter. They are confronting disowned parts of themselves. The Yakshi’s irresistible beauty reflects their desire, while her terrifying, bloodthirsty violence symbolises their guilt and fear of unacceptable desires. 
Health, Medical, Opinion

Treat ghosts who lure men to their demise as a guide, and not a villain

Schizophrenia is a complex neurobiological disorder that can have long-term effects. Unfortunately, it remains one of the most heavily stigmatised diagnoses in psychiatry.
Health, Medical, Opinion

A schizophrenic? Warm up to ‘a person with schizophrenia’ 

Get The Best Stories
into Your inbox!

Subscription 03

Be the first to know about our exciting News from your favorite products